Search Results - "VUOLTEENAHO, O."

Mast cell degranulation via MRGPRX2 by isolated human albumin fragments by Karhu, T., Akiyama, K., Vuolteenaho, O., Bergmann, U., Naito, T., Tatemoto, K., Herzig, K.-H.

“…Mast cells are important modulators of the human immune system via their release of several inflammatory mediators and proteases. The release can be activated…”
Get full text

Isolation of new ligands for orphan receptor MRGPRX1—hemorphins LVV-H7 and VV-H7 by Karhu, T., Akiyama, K., Vuolteenaho, O., Bergmann, U., Naito, T., Tatemoto, K., Herzig, K.-H.

“…•Two new ligands for the MRGPRX1 were isolated by consecutive HPLC purifications from human platelet preparation.•The ligands were identified as…”
Get full text

Human fetal cardiovascular profile score and neonatal outcome in intrauterine growth restriction by Mäkikallio, K., Räsänen, J., Mäkikallio, T., Vuolteenaho, O., Huhta, J. C.

“…Objective To determine whether low cardiovascular profile (CVP) score has prognostic value for predicting neonatal mortality and severe morbidity in human…”
Get full text

Natriuretic peptides and mortality after stroke by MÄKIKALLIO, A. M, MÄKIKALLIO, T. H, KORPELAINEN, J. T, VUOLTEENAHO, O, TAPANAINEN, J. M, YLITALO, K, SOTANIEMI, K. A, HUIKURI, H. V, MYLLYLÄ, V. V

“…Measurement of natriuretic peptides provides prognostic information in various patient populations. The prognostic value of natriuretic peptides among patients…”
Get full text

Cardiovascular hemodynamics and umbilical artery N‐terminal peptide of proB‐type natriuretic peptide in human fetuses with growth restriction by Girsen, A., Ala‐Kopsala, M., Mäkikallio, K., Vuolteenaho, O., Räsänen, J.

“…Objective To test our hypothesis that human fetal N‐terminal peptide of proB‐type natriuretic peptide (NT‐proBNP) secretion is increased in proportion to the…”
Get full text

Endothelin-1 signalling controls early embryonic heart rate in vitro and in vivo by Karppinen, S., Rapila, R., Mäkikallio, K., Hänninen, S. L., Rysä, J., Vuolteenaho, O., Tavi, P.

“…Aim Spontaneous activity of embryonic cardiomyocytes originates from sarcoplasmic reticulum (SR) Ca2+ release during early cardiogenesis. However, the…”
Get full text

Natriuretic peptides during the development of doxorubicin‐induced left ventricular diastolic dysfunction by Nousiainen, T., Vanninen, E., Jantunen, E., Puustinen, J., Remes, J., Rantala, A., Vuolteenaho, O., Hartikainen, J.

“… Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A, Vuolteenaho O, Hartikainen J (Kuopio University Hospital, Kuopio; Satakunta Central…”
Get full text

Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men by Kurl, S, Ala-Kopsala, M, Ruskoaho, H, Mäkikallio, T, Nyyssönen, K, Vuolteenaho, O, Sivenius, J, Salonen, J T, Laukkanen, J A

“…Risk stratification for cardiovascular outcomes is gaining importance in general population. Prognostic value of natriuretic peptides has been established in…”
Get more information

N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension by Partanen, N, Husso, M, Vuolteenaho, O, Sipola, P, Ruskoaho, H, Peuhkurinen, K, Magga, J

“…Early detection of left ventricular hypertrophy (LVH) is beneficial, since treatment-induced regression of LVH has been unequivocally associated with a better…”
Get full text

Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis by Peltonen, Tuomas, Taskinen, Panu, Näpänkangas, Juha, Leskinen, Hanna, Ohtonen, Pasi, Soini, Ylermi, Juvonen, Tatu, Satta, Jari, Vuolteenaho, Olli, Ruskoaho, Heikki

“…Aims Aortic valve stenosis (AS) is an actively regulated process like atherosclerosis, which is accompanied by changes e.g. in endothelin-related genes…”
Get full text

Characterization of promoter elements required for cardiac chamber-specific expression by Majalahti, T., Tokola, H., Ruskoaho, H., Vuolteenaho, O.

“…Salmon cardiac natriuretic peptide (sCP, an A-type natriuretic peptide) is an excellent model for the study of cardiac chamber-specific gene expression because…”
Get full text

The mixed‐lineage kinase 1–3 signalling pathway regulates stress response in cardiac myocytes via GATA‐4 and AP‐1 transcription factors by Ola, A, Kerkelä, R, Tokola, H, Pikkarainen, S, Skoumal, R, Vuolteenaho, O, Ruskoaho, H

“…Background and purpose:  The mixed‐lineage kinases (MLKs) act upstream of mitogen‐activated protein kinases, but their role in cardiac biology and pathology is…”
Get full text

Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation by KUITTINEN, T, HUSSO-SAASTAMOINEN, M, SIPOLA, P, VUOLTEENAHO, O, ALA-KOPSALA, M, NOUSIAINEN, T, JANTUNEN, E, HARTIKAINEN, J

“…Cardiotoxicity is potentially the most threatening nonhaematological side effect of high-dose CY. We prospectively evaluated the very acute cardiac effects of…”
Get full text

Strong relationship between NT-proXNP levels and cardiac output following cardiac surgery in neonates and infants by BREUER, T., SKOUMAL, R., HORKAY, F., MERKELY, B., ALA-KOPSALA, M., LEPPÄLUOTO, J., VUOLTEENAHO, O., RUSKOAHO, H., TÓTH, M., SZÉKELY, A.

“…Background: NT‐proXNP, a new natriuretic peptide analyte, incorporates information about the concentrations of both N‐terminal pro‐atrial and pro‐brain…”
Get full text

Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation by Kuittinen, T., Jantunen, E., Vanninen, E., Mussalo, H., Vuolteenaho, O., Ala-Kopsala, M., Nousiainen, T., Hartikainen, J.

“…: Objectives:  Limited data are available on the cardiac effects of high‐dose cyclophosphamide (CY) in patients with non‐Hodgkin's lymphoma (NHL). We…”
Get full text

Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma by Nousiainen, T., Jantunen, E., Vanninen, E., Remes, J., Vuolteenaho, O., Hartikainen, J.

“…:  Thirty adult patients with non‐Hodgkin's lymphoma who were planned to receive up to 8–10 cycles of CHOP (cyclophosphamide, doxorubicin, vincristine and…”
Get full text

Prediction of atrial fibrillation after coronary artery bypass grafting by measuring atrial peptide levels and preoperative atrial dimensions by Hakala, T., Hedman, A., Turpeinen, A., Kettunen, R., Vuolteenaho, O., Hippeläinen, M.

“…Objective: We prospectively tested the hypothesis that atrial enlargement and increased level of atrial natriuretic peptide, N-terminal atrial natriuretic…”
Get full text

Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression by Majalahti-Palviainen, T, Hirvinen, M, Tervonen, V, Ilves, M, Ruskoaho, H, Vuolteenaho, O

“…Volume excess and mechanical load lead to the induction of the endocrine activity of the heart. The increased production and secretion of A- and B-type…”
Get full text

Calmodulin kinase modulates Ca2+ release in mouse skeletal muscle by Tavi, Pasi, Allen, David G, Niemelä, Perttu, Vuolteenaho, Olli, Weckström, Matti, Westerblad, Håkan

“…Activation of the contractile machinery in skeletal muscle is initiated by the action-potential-induced release of Ca 2+ from the sarcoplasmic reticulum (SR)…”
Get full text

Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients by Nousiainen, T, Vanninen, E, Jantunen, E, Remes, J, Ritanen, E, Vuolteenaho, O, Hartikainen, J

“…Doxorubicin-induced cardiotoxicity was used as a model to prospectively investigate neuroendocrine changes during the development of left ventricular…”
Get more information